We evaluated the feasibility of embedding periodically arranged squares with planar and vertical texture into a background with a developable-modulation (DM) type cholesteric liquid crystal (CLC) fingerprint texture by a two-step ultraviolet-induced polymerization method. Checker-patterned optical diffractive elements, which can be seen as a variation of a two-dimensional (2D) barcode, were first realized and the dependence of diffraction behaviors on incident light polarization and applied voltage were investigated. Taking advantage of the natural randomness and uncontrollable variations of a DM-type fingerprint textures, a polymer-stabilized CLC (PSCLC) graphic symbol with a 2D barcode pattern was then implemented with enhanced anti-counterfeiting features that are difficult to falsify or duplicate. The results indicate that the multiplexing of nonuniform DM-type fingerprint gratings, cross-polarized light readout, and unique polarization diffraction characteristics can improve the level of security.
We report a magnetically transportable microlaser with cholesteric liquid crystal (CLC) core-shell structure, operating in band-edge mode. The dye doped CLC shells as a water-in-oil-in-water (W/O/W) double emulsion were fabricated by microfluidics. Water-dispersible Fe3O4 magnetic nanoparticles were incorporated in the inner aqueous phase by taking advantage of the immiscibility with the middle CLC oil phase. The influence of temperature and shell thickness on laser properties was discussed in detail. The non-invasive manipulation of microlasers was realized under a magnetic field. The dependence of velocity on the viscosity of the carrying fluid and size of the core-shell structure was theoretically analyzed and experimentally investigated using a prototype electromagnetic platform. We also discussed the design principles for this type of DDCLC core-shell structure. Such magnetically transportable microlasers offer promise in in-channel illumination applications requiring active control inside micro-channels.
The
copper nanowire (Cu NW) network is considered a promising alternative
to indium tin oxide as transparent conductors for advanced optoelectronic
devices. However, the fast degradation of copper in ambient conditions
largely overshadows its practical applications. Here we demonstrate
a facile method for epitaxial growth of hexagonal boron nitride (h-BN)
of a few atomic layers on interlaced Cu NWs by low-pressure chemical
vapor deposition, which exhibit excellent thermal and chemical stability
under high temperature (900 °C in vacuum), high humidity (95%
RH), and strong base/oxidizer solution (NaOH/H2O2). Meanwhile, their optical and electrical performances remain similar
to those of the original Cu NWs (e.g., high optical transmittance (∼93%) and high conductivity
(60.9 Ω/□)). A smart privacy glass is successfully fabricated
based on a Cu@h-BN NW network and liquid crytal, which could rapidly
control the visibility from transparent to opaque (0.26 s) and, at
the same time, strongly block the mid-infrared light for energy saving
by screening radiative heat. This precise engineering of epitaxial
Cu@h-BN core–shell nanostructure offers broad applications
in high-performance electronic and optoelectronic devices.
This paper presents a fully integrated CMOS multimodality joint sensor/stimulator array with 1024 pixels for real-time holistic cellular characterization and drug screening. The proposed system consists of four pixel groups and four parallel signal-conditioning blocks. Every pixel group contains 16 × 16 pixels, and each pixel includes one gold-plated electrode, four photodiodes, and in-pixel circuits, within a pixel footprint. Each pixel supports real-time extracellular potential recording, optical detection, charge-balanced biphasic current stimulation, and cellular impedance measurement for the same cellular sample. The proposed system is fabricated in a standard 130-nm CMOS process. Rat cardiomyocytes are successfully cultured on-chip. Measured high-resolution optical opacity images, extracellular potential recordings, biphasic current stimulations, and cellular impedance images demonstrate the unique advantages of the system for holistic cell characterization and drug screening. Furthermore, this paper demonstrates the use of optical detection on the on-chip cultured cardiomyocytes to real-time track their cyclic beating pattern and beating rate.
Cells are complex systems with concurrent multi-physical responses, and cell physiological signals are often encoded with spatiotemporal dynamics and further coupled with multiple cellular activities. However, most existing electronic sensors are only single-modality and cannot capture multi-parametric cellular responses. In this paper, a 1024-pixel CMOS quad-modality cellular interfacing array that enables multi-parametric cell profiling for drug development is presented. The quad-modality CMOS array features cellular impedance characterization, optical detection, extracellular potential recording, and biphasic current stimulation. The fibroblast transparency and surface adhesion are jointly monitored by cellular impedance and optical sensing modalities for comprehensive cell growth evaluation. Simultaneous current stimulation and opto-mechanical monitoring based on cardiomyocytes are demonstrated without any stimulation/sensing dead-zone. Furthermore, drug dose-dependent multi-parametric feature extractions in cardiomyocytes from their extracellular potentials and opto-mechanical signals are presented. The CMOS array demonstrates great potential for fully automated drug screening and drug safety assessments, which may substantially reduce the drug screening time and cost in future new drug development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.